Quarterly Result2 Aug 2025, 02:06 pm
Epigral Ltd Reports Q1 FY26 Revenue of ₹ 615 Crore, PAT at ₹ 160 Crore
AI Summary
Epigral Ltd, a leading integrated chemical manufacturer in India, has announced its financial results for the quarter ended June 30, 2025. The company posted a revenue of ₹ 615 Crore, a decrease of 6% from the ₹ 654 Crore recorded in Q1FY25. The Profit After Tax (PAT) stood at ₹ 160 Crore, including a decrease in deferred tax liability of ₹ 81 Cr, compared to ₹ 86 Crore in Q1FY25. The company maintained its EBITDA margin at 27% despite a drop in volume and realizations. The capex projects for expanding CPVC and Epichlorohydrin capacity are moving as per schedule and are expected to be commissioned within the target timeline and budget.
Key Highlights
- Revenue for Q1FY26 stood at ₹ 615 Crore, a decrease of 6% from Q1FY25
- PAT for Q1FY26 was ₹ 160 Crore, including a decrease in deferred tax liability of ₹ 81 Cr
- EBITDA margin remained unchanged at 27% on account of sustained focus on efficiency and product mix
- Capex projects for expanding CPVC and Epichlorohydrin capacity are moving as per schedule
- ROCE grew to 24% as on 30th June 2025 vs 21% as on 30th June 2024